$1.97
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Country

US

CEO

Ms. Leslie Campbell

IPO date

2000

Employees

173

ISIN

US7163821066

Key stats

Open

$1.95

Volume

165.77K

Market cap

$41.89M

Prev. close

$1.96

Impl / hst vl

-

Open interest

$0.00

$1.95

Day’s Range

$2.00

$1.62

52W Range

$3.70

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
0.24
P/B
1.49
Current ratio
0.84
Debt / Equity
-0.74
ROE
-146.59%
Gross margin
32.56%
Income growth
-61.52%
FCF growth
-40.51

Aug

18

Dividends

The last payment date was Aug 18, 2023

Div. per Share

$0.30

Div. Yield

15.31%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 2 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$2.19
The top 3 analysts forecasts that 12-month price may increase by 11.32%, with a low of $2.17 and a high of $2.26
$2.17
Low
$2.19
Avg
$2.26
High
Current price

Earnings

Q1 ‘26 revenue
$42.82M
Q1 ‘26 net income
-$4.06M
Revenue
Net income
Previous EPS
-
Estimate EPS
-$0.06
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply